Experience in the treatment of psoriasis patients using Apremilast, a selective signalling pathway inhibitor
| Autor: | N. V. Kungurov, N. V. Zilberberg, M. M. Kokhan, J. V. Keniksfest, E. V. Grishaeva |
|---|---|
| Jazyk: | English<br />Russian |
| Rok vydání: | 2019 |
| Předmět: | |
| Zdroj: | Vestnik Dermatologii i Venerologii, Vol 94, Iss 6, Pp 67-76 (2019) |
| Druh dokumentu: | article |
| ISSN: | 0042-4609 2313-6294 |
| DOI: | 10.25208/0042-4609-2018-94-6-67-76 |
| Popis: | The article presents a brief description of Аpremilast — the target synthetic anti-inflammatory drug, which is representative of a new class of agents for the treatment of psoriasis and psoriatic arthritis. The efficiency and safety of the new drug in the treatment of patients with severe psoriasis are shown. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|